Nottingham, United Kingdom

Colin D Melia

This inventor holds 1 USPTO granted patent. Top assignee: The Boots Company Plc. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Colin D Melia. Retrieved from https://idiyas.com/inventor/colin-d-melia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 50(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Colin D Melia: Innovator in Pharmaceutical Formulations

Introduction

Colin D Melia is a notable inventor based in Nottingham, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of sustained release formulations. His work focuses on improving the efficacy and delivery of therapeutic agents.

Latest Patents

Colin D Melia holds 1 patent for a therapeutic agent. His patent describes a sustained release pharmaceutical formulation that comprises xanthan gum, a pharmaceutically active ingredient such as ibuprofen or flurbiprofen, along with other optional excipients. This innovation aims to enhance the delivery and effectiveness of pain relief medications.

Career Highlights

Colin is associated with The Boots Company Plc, where he applies his expertise in pharmaceutical sciences. His role involves research and development, focusing on creating innovative solutions for healthcare.

Collaborations

Colin has collaborated with notable colleagues, including Mahendra Govind Pankhania and John F Lampard. These partnerships have contributed to the advancement of pharmaceutical technologies and formulations.

Conclusion

Colin D Melia's work in pharmaceutical formulations exemplifies the impact of innovation in healthcare. His contributions continue to influence the development of effective therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…